Artificial intelligence predicts lung cancer radiotherapy response: A meta-analysis

[1]  Qi-wen Li,et al.  CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal environment , 2022, Radiation Oncology.

[2]  H. Liu,et al.  Radiomic Features of Tumor and Tumor Organismal Environment in Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiotherapy: A Retrospective Analysis of Survival Prediction. , 2021, International journal of radiation oncology, biology, physics.

[3]  A. Madabhushi,et al.  Predicting cancer outcomes with radiomics and artificial intelligence in radiology , 2021, Nature Reviews Clinical Oncology.

[4]  S. Peters,et al.  Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging , 2021, EJNMMI Research.

[5]  I. Naqa,et al.  Combining computed tomography and biologically effective dose in radiomics and deep learning improves prediction of tumor response to robotic lung SBRT. , 2021, Medical physics.

[6]  Chia-Feng Lu,et al.  Enhancement of Radiosurgical Treatment Outcome Prediction Using MRI Radiomics in Patients with Non-Small Cell Lung Cancer Brain Metastases , 2021, Cancers.

[7]  H. Aerts,et al.  Artificial Intelligence Applications to Improve the Treatment of Locally Advanced Non-Small Cell Lung Cancers , 2021, Cancers.

[8]  W. Jiang,et al.  The G4 Resolvase DHX36 Possesses a Prognosis Significance and Exerts Tumour Suppressing Function Through Multiple Causal Regulations in Non-Small Cell Lung Cancer , 2021, Frontiers in Oncology.

[9]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[10]  R. T. Ten Haken,et al.  Integrating multi-omics information in deep learning architectures for joint actuarial outcome prediction in non-small-cell lung cancer patients after radiation therapy. , 2021, International journal of radiation oncology, biology, physics.

[11]  Nicholas G Zaorsky,et al.  A systematic review and meta-analysis of the prognostic value of radiomics based models in non-small cell lung cancer treated with curative radiotherapy. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  B. Nemesure,et al.  Risk Stratification of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Chemo-Radiotherapy: An Institutional Analysis , 2020, Cancer management and research.

[13]  M. Shaban,et al.  Use of artificial intelligence in diagnosis of head and neck precancerous and cancerous lesions: A systematic review. , 2020, Oral oncology.

[14]  Shuhao Wang,et al.  Emerging role of deep learning‐based artificial intelligence in tumor pathology , 2020, Cancer communications.

[15]  A. Luciani,et al.  Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer , 2020, European Radiology.

[16]  J. Roth,et al.  Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients. , 2020, Clinical lung cancer.

[17]  Luis A. de Souza,et al.  A technical review of artificial intelligence as applied to gastrointestinal endoscopy: clarifying the terminology , 2019, Endoscopy International Open.

[18]  Dimitris Visvikis,et al.  Pretreatment 18F-FDG PET/CT Radiomics Predict Local Recurrence in Patients Treated with Stereotactic Body Radiotherapy for Early-Stage Non–Small Cell Lung Cancer: A Multicentric Study , 2019, The Journal of Nuclear Medicine.

[19]  H. Aerts,et al.  Distributed radiomics as a signature validation study using the Personal Health Train infrastructure , 2019, Scientific Data.

[20]  T. Coroller,et al.  Deep Learning Predicts Lung Cancer Treatment Response from Serial Medical Imaging , 2019, Clinical Cancer Research.

[21]  Yolande Lievens,et al.  Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  M. Astaraki,et al.  Early survival prediction in non-small cell lung cancer from PET/CT images using an intra-tumor partitioning method. , 2019, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[23]  Brian J. Smith,et al.  Deep segmentation networks predict survival of non-small cell lung cancer , 2019, Scientific Reports.

[24]  V. Visser-Vandewalle,et al.  Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy , 2019, Strahlentherapie und Onkologie.

[25]  Berkman Sahiner,et al.  Deep learning in medical imaging and radiation therapy. , 2018, Medical physics.

[26]  R. Gillies,et al.  Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study , 2018, PLoS medicine.

[27]  C. Simone,et al.  Unsupervised machine learning of radiomic features for predicting treatment response and overall survival of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  S. Park,et al.  Methodologic Guide for Evaluating Clinical Performance and Effect of Artificial Intelligence Technology for Medical Diagnosis and Prediction. , 2018, Radiology.

[29]  James A. Bartholomai,et al.  Prediction of lung cancer patient survival via supervised machine learning classification techniques , 2017, Int. J. Medical Informatics.

[30]  Boris Sepesi,et al.  Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer. , 2017, International journal of radiation oncology, biology, physics.

[31]  Sherri Rose,et al.  Classifying Lung Cancer Severity with Ensemble Machine Learning in Health Care Claims Data , 2017, MLHC.

[32]  Bram van Ginneken,et al.  A survey on deep learning in medical image analysis , 2017, Medical Image Anal..

[33]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[34]  Susan Mallett,et al.  QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies , 2011, Annals of Internal Medicine.

[35]  A. Stang.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[36]  Ping Yang,et al.  Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. , 2008, Mayo Clinic proceedings.

[37]  S W Lagakos,et al.  Nonparametric estimation of lifetime and disease onset distributions from incomplete observations. , 1982, Biometrics.

[38]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[39]  C. Le Berre,et al.  Application of Artificial Intelligence to Gastroenterology and Hepatology. , 2019, Gastroenterology.

[40]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[41]  M Oudkerk,et al.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[42]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.